MPR Weekly Dose 81 - A first therapy to target underlying process of Alzheimer disease; Moderna requests EUA; And a list of new approvals in a variety of therapeutic categories
This week it's the big one: aducanumab - a treatment for alzheimer disease - got FDA approval. We'll go into that, plus a semaglutide treatment for obesity, a first treatment for Plasminogen Deficienc...
11 Kesä 202114min
MPR Weekly Dose 80 - Migraine prevention treatment; Pediatric combo vaccine; Schizophrenia, Bipolar I approval; AI-based Autism diagnostic
On this week's show we have news of migraine prevention treatment, a hexavalent vaccine is approved for pediatrics, there's also an approval for schizophrenia and bipolar I disorder, lumakras gets fas...
4 Kesä 202110min
MPR Weekly Dose 79 - COVID-19: vaccine storage, efficacy updates; Gene therapy Fast Tracked; Vitiligo cream trial results; Aspirin dosage compared in ASCVD
This week we have news of a change to the storage of the Pfizer-BioNTech vaccine; A gene therapy gets Fast Track status by the FDA; Vitiligo cream shows promise in clinical trials; And outcomes in ath...
21 Touko 20219min
MPR Weekly Dose 78 - Vaccine authorized for adolescents; Postoperative pain Tx approval; Insulin products recalled; Treatment Fast Tracked for facioscapulohumeral muscular dystrophy
This week we have news of a COVID-19 vaccine authorization expanded for adolescents; A new postoperative pain treatment; There's a new insulin smart pen devices; Insulin products are recalled; And the...
14 Touko 202113min
MPR Weekly Dose 77 - Updated mask guidance; Janssen vaccine resumption; Steroid therapy in COVID-19; Novel MDD gains Priority Review; Scabies treatment; Stroke rehabilitation device
New guidelines on mask use; J&J vaccine update; Novel major depressive disorder treatment gains Priority Review; A scabies topical suspension; And a device to help stroke rehabilitation.
30 Huhti 202110min
MPR Weekly Dose 76 - Bamlanivimab emergency use changes; Janssen vaccine facilities; Molnupiravir trial halted; New contraceptive approved; Ragweed pollen allergy treatment
The FDA revoke Emergency Use Authorization for bamlanivimab; Issues identified at a Janssen manufacturing facility; Merck halts trials for investigational COVID-19 therapy; A new contraceptive is appr...
23 Huhti 202113min
MPR Weekly Dose 75 - Janssen vaccine on pause; Antibody therapy guidance; Remote mifepristone dispensing; Xolair self-administration; And a new AI colonoscopy system
The latest status on the Janssen vaccine; Updated guidance from the National Institutes of Health on COVID-19 antibody treatments; The FDA changes in-person mifepristone dispensing; Xolair prefilled s...
16 Huhti 202111min
MPR Weekly Dose 74 - Updated travel guidance; Six month vaccine efficacy data; Increased Moderna doses per vial; New ADHD treatment; And a safety communication for lamotrigine
Back to regular programming this week with a summary of the top news, which includes updated travel guidance; Six month efficacy data for the Moderna and Pfizer-BioNTech vaccines; Vial doses increased...
9 Huhti 202111min
